Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-153,790
Closed -$306K 133
2025
Q2
$306K Buy
+153,790
New +$281K 0.37% 41

Rangeley Capital's HLVX Position: Q3 2025 in Review

Rangeley Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 153,790 shares — an estimated $306K sold.

Rangeley Capital first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $306K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Rangeley Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Rangeley Capital sold 153,790 HilleVax shares in Q3 2025, an estimated $306K.
  • Rangeley Capital first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Rangeley Capital's HilleVax position peaked at $306K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.